Adalimumab

Results: 358



#Item
51Public Summary Document – November 2014 PBAC Meeting 6.3 CERTOLIZUMAB PEGOL 200 mg/mL injection, 2 x 1 mL syringes;

Public Summary Document – November 2014 PBAC Meeting 6.3 CERTOLIZUMAB PEGOL 200 mg/mL injection, 2 x 1 mL syringes;

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
52Microsoft Wordcertolizumab pegol PSDFINAL.doc

Microsoft Wordcertolizumab pegol PSDFINAL.doc

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-23 21:11:42
53® SIMPONI Golimumab (rmc) Consumer Medicine Information

® SIMPONI Golimumab (rmc) Consumer Medicine Information

Add to Reading List

Source URL: www.janssen.com.au

Language: English - Date: 2014-05-06 00:24:48
54Arthritis / Autoimmune diseases / Immunosuppressants / Monoclonal antibodies / Psoriatic arthritis / Ankylosing spondylitis / TNF inhibitor / Biologic / Adalimumab / Medicine / Health / Rheumatology

Top Ten Quality Standards for Spondyloarthritis People with spondyloarthritis (SpA) evidenced by inflammatory back pain (IBP) for more than 3 months or arthritis suggestive of psoriatic arthritis, reactive arthritis or

Add to Reading List

Source URL: www.rheumatology.org.uk

Language: English - Date: 2013-02-15 09:07:18
55Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 1 to Wave 1 Case Study Report 1:b:iii: Raptiva® (efalizumab)

Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 1 to Wave 1 Case Study Report 1:b:iii: Raptiva® (efalizumab)

Add to Reading List

Source URL: protectbenefitrisk.eu

Language: English - Date: 2014-07-16 01:09:12
56Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Report 1:b:iii Benefit - Risk Wave 1 Case Study Report: Raptiva® (efalizumab)

Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Report 1:b:iii Benefit - Risk Wave 1 Case Study Report: Raptiva® (efalizumab)

Add to Reading List

Source URL: protectbenefitrisk.eu

Language: English - Date: 2014-07-16 01:09:12
57Biologic drugs for rheumatoid arthritis 1 Biologic drugs (or ‘biologics’) are designed to act on the specific parts of your immune system which cause inflammation in your joints. Biologics are used

Biologic drugs for rheumatoid arthritis 1 Biologic drugs (or ‘biologics’) are designed to act on the specific parts of your immune system which cause inflammation in your joints. Biologics are used

Add to Reading List

Source URL: www.arthritiscare.org.uk

Language: English - Date: 2015-02-04 08:07:33
58Pisetsky Arthritis Research & Therapy 2012, 14:125 http://arthritis-research.com/contentE D I TO R I A L 4th International Forum on Rheumatoid Arthritis:

Pisetsky Arthritis Research & Therapy 2012, 14:125 http://arthritis-research.com/contentE D I TO R I A L 4th International Forum on Rheumatoid Arthritis:

Add to Reading List

Source URL: arthritis-research.com

Language: English
59Prospection submission REVIEW OF AUTHORITY REQUIRED PBS LISTINGS DR PETER CRONIN Review of Authority Required PBS Listings Prospection is a health analytics company. We have considerable experience working with the PBS

Prospection submission REVIEW OF AUTHORITY REQUIRED PBS LISTINGS DR PETER CRONIN Review of Authority Required PBS Listings Prospection is a health analytics company. We have considerable experience working with the PBS

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-03-02 18:33:43
60Clinical Commissioning Policy: Infliximab (Remicade) and Adalimumab (Humira) As Anti-TNF Treatment Options For Adult Patients with Severe Refractory Uveitis Reference: NHS England D12/P/b

Clinical Commissioning Policy: Infliximab (Remicade) and Adalimumab (Humira) As Anti-TNF Treatment Options For Adult Patients with Severe Refractory Uveitis Reference: NHS England D12/P/b

Add to Reading List

Source URL: www.engage.england.nhs.uk

Language: English - Date: 2015-03-23 14:20:26